Your Messages Inbox
Your Article Summary
See Latest ArticlesBioMimetic Therapeutics, Inc. Announces Completion of Rights Offering and Sale of Shares in Standby Purchase
BioMimetic Therapeutics, 06/26/09
BioMimetic Therapeutics, Inc. announced that it has closed its previously announced rights offering. The Company received valid subscriptions for all of shares purchasable in the rights offering, including shares subscribed for by certain of the Company's stockholders in the exercise of their over-subscription rights, at a subscription price of $8.50 per share. The Company issued the shares purchased in the rights offering to the purchasers on June 2009.
Today in Marketing/Media/ROI...keeping you current
Receive free subspecialty "5-minute updates" via email
Chugai Revises Corporate Advertisement for First Time in Four Years
Chugai Pharmaceutical Co., 11/25/09
Boston Scientific Announces FDA Clearance and CE Mark for WallFlex Fully Covered Esophageal Stent
Boston Scientific, 11/24/09
Medtronic Introduces 3D Recon Service to Enhance Endovascular Treatment of Aortic Aneurysms
Medtronic, 11/20/09
Article Search
Sponsor